The latest financial statement is for the quarter ending 2026-02-28.
| Cash Flow | 2026-02-28 | 2025-11-29 | 2025-08-30 |
|---|---|---|---|
| Net income including non-controlling interest | 21,045 | 29,731 | 122,342 |
| Depreciation | 24,354 | 23,460 | 68,314 |
| Amortization | 22,011 | 22,021 | 64,525 |
| Deferred income taxes | -2,422 | -10,867 | -39,227 |
| Loss on impairment of intangible asset | - | 446 | 478 |
| Income from equity method investments, net of dividends received | 918 | 1,058 | -1,045 |
| Loss (gain) on sale or disposal of assets | -1,029 | 3,524 | 178 |
| Pension and other postretirement benefit plan contributions | - | 3,267 | - |
| Share-based compensation | 5,348 | 3,885 | 18,170 |
| Pension and other post-retirement benefit plan activity | -1,862 | -14,193 | -7,047 |
| Gain from insurance proceeds | - | 0 | 0 |
| Loss on impairment of assets held for sale | - | 0 | - |
| Debt issuance cost write-off | - | 0 | - |
| Loss on impairment of equity investment | - | 0 | 0 |
| (gain) loss on fair value adjustment on contingent consideration liabilities | - | 0 | - |
| Loss on the sale of a business | 0 | -812 | -1,515 |
| Trade receivables, net | -39,563 | 99 | 3,336 |
| Inventories | 28,861 | -31,777 | 42,095 |
| Other assets | 3,224 | 21,179 | 7,530 |
| Trade payables | 3,048 | -12,400 | -25,764 |
| Accrued compensation | -46,425 | 24,136 | -19,230 |
| Other accrued expenses | -12,537 | 28,678 | 6,856 |
| Income taxes payable | -12,699 | 6,903 | -12,993 |
| Other liabilities | -9,854 | 6,255 | 28,622 |
| Foreign currency remeasurement | 1,570 | 4,780 | -2,289 |
| Net cash used in operating activities | -3,974 | 106,737 | 156,756 |
| Purchased property, plant and equipment | 57,701 | 47,682 | 94,593 |
| Purchase of non-controlling interest | - | 1,170 | - |
| Purchased businesses, net of cash acquired | 0 | 4,912 | 162,095 |
| Proceeds from sale of property, plant and equipment | 321 | 4,182 | 843 |
| Purchase of cost method investment | 0 | 0 | 2,549 |
| Proceeds from insurance recoveries | - | 0 | - |
| Proceeds from the sale of a business | 0 | 0 | 75,727 |
| Net cash used in investing activities | -57,380 | -49,582 | -182,667 |
| Proceeds from issuance of long-term debt | 288,100 | 186,000 | 1,114,300 |
| Repayment of long-term debt | 231,441 | 251,841 | 1,053,593 |
| Payment of debt issue costs | - | 0 | 1,047 |
| Net payment of notes payable | 0 | -2 | -585 |
| Dividends paid | 12,798 | 12,712 | 37,559 |
| Proceeds from stock options exercised | 7,798 | 4,329 | 5,519 |
| Repurchases of common stock | 2,922 | -15 | 60,728 |
| Contingent consideration payment | - | 0 | - |
| Net cash provided by financing activities | 48,737 | -74,211 | -33,693 |
| Effect of exchange rate changes on cash and cash equivalents | 13,281 | 1,811 | 12,710 |
| Net change in cash and cash equivalents | 664 | -15,245 | -46,894 |
| Cash and cash equivalents at beginning of period | 107,213 | 122,458 | 169,352 |
| Cash and cash equivalents at end of period | 107,877 | 107,213 | 122,458 |
FULLER H B CO (FUL)
FULLER H B CO (FUL)